This is a 16-day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
248
Ophthalmic drops, BID pre- and post-operation, and 6 doses on surgery day. Placebo
Unnamed facility
Artesia, California, United States
Resolution of Post Operative Inflammation
Anterior chamber inflammation is the sum of biomicroscopic cell and flare; each measured on a scale of 0-4 (Flare: 0 = no flare, 4 = intense flare / Cell: 0 = no cells, 4 = \>50 cells)
Time frame: Day 14
Ocular Pain
Measured on a scale of 0-4 (0 = none, 4 = intolerable)
Time frame: Day 1
Mean Pupil Area
Pupil area post-irrigation and aspiration
Time frame: Day 0
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.